Cat immunisation vectors
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Jul 14, 2005
app pub date -
Dec 27, 2004
filing date -
Feb 22, 2002
priority date (Note) -
Abandoned
status (Latency Note)
Importance
Abstract
Cat C3d polypeptide, fragments thereof, and nucleic acid sequences encoding the polypeptide and fragments are described. Genetic constructs encoding such polypeptides can be used to enhance the immunogenicity of antigens in cats. Variant nucleic acid sequences encoding cat C3d polypeptides, when used to express tandem arrays of the polypeptide show enhanced stability, leading to high level expression in eukaryotic and prokaryotic cell expression systems. When incorporated into a DNA immunization vector or a recombinant live organism vaccine, the variant sequences have reduced risk of undergoing homologous recombination with genomic DNA compared to wild-type sequences, thus reducing the risk of potentially damaging integration events.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully